Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v2-FR
Language French French
Date Updated 2018-08-02 2018-07-27
Drug Identification Number 02327236 02327236
Brand name METHOTREXATE INJECTION BP METHOTREXATE INJECTION BP
Common or Proper name METHOTREXATE METHOTREXATE
Company Name ACCORD HEALTHCARE INC ACCORD HEALTHCARE INC
Ingredients METHOTREXATE METHOTREXATE
Strength(s) 25MG 25MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRA-ARTERIAL INTRAMUSCULAR INTRATHECAL INTRAVENOUS INTRAVENTRICULAR INTRA-ARTERIAL INTRAMUSCULAR INTRATHECAL INTRAVENOUS INTRAVENTRICULAR
Packaging size 1 VIAL OF 40 ML | 1 FIOLE DE 40 ML 1 VIAL OF 40 ML | 1 FIOLE DE 40 ML
ATC code L01BA L01BA
ATC description ANTIMETABOLITES ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2018-07-17 2018-07-17
Actual start date 2018-07-17 2018-07-17
Estimated end date 2018-08-11 2018-08-11
Actual end date 2018-07-31
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments